Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 4 medicines · Historical list
- Pertussis Vaccine 4 Protect Unit15000 M / ML · Suspension · Aventis Pasteur Limited
- Diphtheria and Tetanus Toxoids with Pertussis Vaccine Adsorbed25 LF / 0.5 ML + 12 UNIT / 0.5 ML + 5 LF / 0.5 ML · Liquid · Aventis Pasteur Limited
- DPT Polio Adsorbed Vaccines25 LF / 0.5 ML + 12 UNIT / 0.5 ML + 80 UNIT / 0.5 ML + 5 LF / 0.5 ML · Liquid · Aventis Pasteur Limited
- Tri-Immunol Liq IM12.5 LF / 0.5 ML + 4 UNIT / 0.5 ML + 5 LF / 0.5 ML · Liquid · Lederle Labs, Division of American Cyanamid Co
European Union
EMA · 1 medicine
New Zealand
PHARMAC · 1 medicine
Taiwan
TFDA · 1 medicine · Historical list
All medicines with Pertussis vaccine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
71 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Pertussis Vaccine 4 Protect Unit | Canada | 15000 M / ML | Suspension | Cancelled | Aventis Pasteur Limited |
| VacPertagen | European Union | Authorised | BioNet Europe | ||
| Diphtheria and Tetanus Toxoids and Pertussis Vaccine AdsorbedCombination | Taiwan | 注射劑 | Cancelled | 法台化學股份有限公司 | |
| Diphtheria and Tetanus Toxoids with Pertussis Vaccine AdsorbedCombination | Canada | 25 LF / 0.5 ML + 12 UNIT / 0.5 ML + 5 LF / 0.5 ML | Liquid | Cancelled | Aventis Pasteur Limited |
| VaxelisCombination | United States | 0.5ML | Injection | Marketed | MSP Vaccine Company |
| VaxelisCombination | United States | 0.5ML | Injection | Marketed | MSP Vaccine Company |
| PediarixCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| PentacelCombination | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| BoostrixCombination | New Zealand | Inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid, 8 mcg pertussis toxoid, 8 mcg pertussis filamentous haemagglutinin and 2.5 mcg pertactin in 0.5 ml prefilled syringe | Funded | ||
| AdacelCombination | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| BoostrixCombination | United States | 2.5LF, 5LF, 2.5UG, 8UG UG/.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| BoostrixCombination | United States | 2.5LF, 5LF, 2.5UG, 8UG UG/.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Daptacel | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| Infanrix | United States | 25LF/10LF/25UG/.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Infanrix | United States | 25LF/10LF/25UG/.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| KinrixCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| QuadracelCombination | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| PertussisCombination | United States | Status unknown | |||
| QuadracelCombination | United States | 0.5ML | Injection | Not marketed | Sanofi Vaccines Canada Ltd. |
| DPT Polio Adsorbed VaccinesCombination | Canada | 25 LF / 0.5 ML + 12 UNIT / 0.5 ML + 80 UNIT / 0.5 ML + 5 LF / 0.5 ML | Liquid | Cancelled | Aventis Pasteur Limited |
| Pentaxim VaccineCombination | Singapore | min. 20 IU (30 Lf)/0.5 mL + 25 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + min. 40 IU (10 Lf) /0.5 mL + 10 μg/0.5 mL + 18 - 30 μg/0.5 mL | injection, powder, for suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Boostrix VaccineCombination | Singapore | 2 iu/0.5 ml + 8 mcg/0.5 ml + 2.5 mcg/0.5 ml + 8 mcg/0.5 ml + 20 iu/0.5 ml | injection | Authorised | Glaxosmithkline Pte LTD |
| Vaxelis | European Union | Authorised | MCM Vaccine B.V. | ||
| Infanrix Hexa VaccineCombination | Singapore | min 30 iu/0.5 ml + 25 mcg/0.5 ml + 10 mcg/0.5 ml + 10 mcg/0.5 ml + 8 mcg/0.5 ml + 25 mcg/0.5 ml + 40 du/0.5 ml + 8 du/0.5 ml + 32 du/0.5 ml + min 40 iu/0.5 ml | injection | Authorised | Glaxosmithkline Pte LTD |
| Infanrix Ipv+Hib VaccineCombination | Singapore | min 30IU/0.5ml + 25mcg/0.5ml + 10 mcg/0.5 ml + 8mcg/0.5ml + 25mcg/0.5ml + 40DU/0.5ml + 8DU/0.5ml + 32DU/0.5ml + min 40IU/0.5ml | injection | Authorised | Glaxosmithkline Pte LTD |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Sources
Compiled by Prognia from the public medicine registers of EMA, Health Canada, PHARMAC and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 4
- Medicines
- 7
- Companies
- 4
